Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75


Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.

Wooldridge AA, Fortner CN, Lontay B, Akimoto T, Neppl RL, Facemire C, Datto MB, Kwon A, McCook E, Li P, Wang S, Thresher RJ, Miller SE, Perriard JC, Gavin TP, Hickner RC, Coffman TM, Somlyo AV, Yan Z, Haystead TA.

J Biol Chem. 2008 Apr 25;283(17):11850-9. doi: 10.1074/jbc.M708628200. Epub 2008 Feb 29.


Smoothelin-like 1 protein regulates myosin phosphatase-targeting subunit 1 expression during sexual development and pregnancy.

Lontay B, Bodoor K, Weitzel DH, Loiselle D, Fortner C, Lengyel S, Zheng D, Devente J, Hickner R, Haystead TA.

J Biol Chem. 2010 Sep 17;285(38):29357-66. doi: 10.1074/jbc.M110.143966. Epub 2010 Jul 15.


Novel contributions of the smoothelin-like 1 protein in vascular smooth muscle contraction and its potential involvement in myogenic tone.

Turner SR, MacDonald JA.

Microcirculation. 2014 Apr;21(3):249-58. doi: 10.1111/micc.12108. Review.


Pregnancy and Smoothelin-like Protein 1 (SMTNL1) Deletion Promote the Switching of Skeletal Muscle to a Glycolytic Phenotype in Human and Mice.

Lontay B, Bodoor K, Sipos A, Weitzel DH, Loiselle D, Safi R, Zheng D, Devente J, Hickner RC, McDonnell DP, Ribar T, Haystead TA.

J Biol Chem. 2015 Jul 17;290(29):17985-98. doi: 10.1074/jbc.M115.658120. Epub 2015 Jun 5.


Binding of smoothelin-like 1 to tropomyosin and calmodulin is mutually exclusive and regulated by phosphorylation.

Ulke-Lemée A, Sun DH, Ishida H, Vogel HJ, MacDonald JA.

BMC Biochem. 2017 Mar 21;18(1):5. doi: 10.1186/s12858-017-0080-6.


Selective phosphorylation of the IP3R-I in vivo by cGMP-dependent protein kinase in smooth muscle.

Murthy KS, Zhou H.

Am J Physiol Gastrointest Liver Physiol. 2003 Feb;284(2):G221-30.


Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase.

Lincoln TM, Wu X, Sellak H, Dey N, Choi CS.

Front Biosci. 2006 Jan 1;11:356-67. Review.


The role of the calponin homology domain of smoothelin-like 1 (SMTNL1) in myosin phosphatase inhibition and smooth muscle contraction.

Borman MA, Freed TA, Haystead TA, Macdonald JA.

Mol Cell Biochem. 2009 Jul;327(1-2):93-100. doi: 10.1007/s11010-009-0047-z. Epub 2009 Feb 14.


Solution structure of the calponin homology (CH) domain from the smoothelin-like 1 protein: a unique apocalmodulin-binding mode and the possible role of the C-terminal type-2 CH-domain in smooth muscle relaxation.

Ishida H, Borman MA, Ostrander J, Vogel HJ, MacDonald JA.

J Biol Chem. 2008 Jul 18;283(29):20569-78. doi: 10.1074/jbc.M800627200. Epub 2008 May 12.


Smoothelin-like 1 protein is a bifunctional regulator of the progesterone receptor during pregnancy.

Bodoor K, Lontay B, Safi R, Weitzel DH, Loiselle D, Wei Z, Lengyel S, McDonnell DP, Haystead TA.

J Biol Chem. 2011 Sep 9;286(36):31839-51. doi: 10.1074/jbc.M111.270397. Epub 2011 Jul 19.


Regulation of contractile activity in vascular smooth muscle by protein kinases.

Silver PJ.

Rev Clin Basic Pharm. 1985 Jul-Dec;5(3-4):341-95. Review.


Mapping and functional characterization of the murine smoothelin-like 1 promoter.

Ulke-Lemée A, Turner SR, Mughal SH, Borman MA, Winkfein RJ, MacDonald JA.

BMC Mol Biol. 2011 Feb 27;12:10. doi: 10.1186/1471-2199-12-10.


Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2.

Huang J, Zhou H, Mahavadi S, Sriwai W, Murthy KS.

Am J Physiol Cell Physiol. 2007 Jan;292(1):C200-8. Epub 2006 Aug 2.


Convergence of Ca2+-desensitizing mechanisms activated by forskolin and phenylephrine pretreatment, but not 8-bromo-cGMP.

Porter M, Evans MC, Miner AS, Berg KM, Ward KR, Ratz PH.

Am J Physiol Cell Physiol. 2006 Jun;290(6):C1552-9. Epub 2006 Jan 18.


Myosin phosphatase isoform switching in vascular smooth muscle development.

Payne MC, Zhang HY, Prosdocimo T, Joyce KM, Koga Y, Ikebe M, Fisher SA.

J Mol Cell Cardiol. 2006 Feb;40(2):274-82. Epub 2005 Dec 13.


Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.

Aizawa T, Wei H, Miano JM, Abe J, Berk BC, Yan C.

Circ Res. 2003 Sep 5;93(5):406-13. Epub 2003 Aug 14.


A cysteine-rich LIM-only protein mediates regulation of smooth muscle-specific gene expression by cGMP-dependent protein kinase.

Zhang T, Zhuang S, Casteel DE, Looney DJ, Boss GR, Pilz RB.

J Biol Chem. 2007 Nov 16;282(46):33367-80. Epub 2007 Sep 18.

Supplemental Content

Support Center